Company Filing History:
Years Active: 1976-1981
Title: Innovative Contributions of Inventor Andre Farcilli
Introduction
Andre Farcilli, an accomplished inventor based in Rosny-sous-Bois, France, has made significant contributions to the field of pharmaceuticals through his inventive prowess. With a total of three patents to his name, Farcilli is recognized for his groundbreaking work in cerebral vasodilation.
Latest Patents
Farcilli's latest patents include the development of new 20,21-dinoreburnamenine derivatives, which are characterized by a specific molecular formula where the hydroxyl group in the 14-position can occupy either of two possible configurations. These innovative compounds have been shown to effectively influence cerebral vascular circulation and are prepared by reducing the corresponding 14-oxoderivatives. Another notable patent involves 14-imino-(15H)-eburnamine compounds, which exist in both racemic mixtures and optically active isomers. These derivatives serve as oxygenators and cerebral vasoregulators with substantial therapeutic value.
Career Highlights
Farcilli has dedicated his career to advancing medical science, particularly in areas that enhance cerebral health. His patents highlight the potential for developing pharmaceutical formulations that address critical conditions surrounding cerebral vascular circulation, showcasing his commitment to innovative healthcare solutions.
Collaborations
Throughout his career, Farcilli has had the opportunity to collaborate with esteemed colleagues such as Italo Medici and Julien Warnant. These partnerships have further enriched his research and innovation endeavors, enabling him to combine expertise and share insights that catalyze advancements in the field.
Conclusion
Andre Farcilli's innovative contributions and patents play a crucial role in the ongoing development of pharmaceutical therapies. His work at Roussel Uclaf underscores his dedication to improving cerebral health through scientific innovation. With each patent, Farcilli continues to make a lasting impact on the medical community.